SYDNEY MOORE: Open Payments
NPI 1952993867 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,162 in 24 payments from 10 companies in 2025. Trend: 2023 $1,745 · 2024 $1,865 · 2025 $2,162
Speaker / faculty: $1,440Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 12 | $1,885 |
| Dendreon Pharmaceuticals LLC | 2 | $54 |
| Verity Pharmaceuticals Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Caris MPI, Inc. | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Endo USA, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $17 |
Products named: INTERSTIM, PROVENGE, Tlando, KEYTRUDA, MI CANCER SEEK, Nubeqa, XIAFLEX, ORGOVYX.
Industry payments across TX — which companies pay providers there.
